PHC Holdings Corp
TSE:6523
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| JP |
|
PHC Holdings Corp
TSE:6523
|
137.8B JPY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
139.3B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
130.9B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
117.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.1B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -122 700% |
| 30th Percentile | 2.9% |
| Median | 5.4% |
| 70th Percentile | 8.5% |
| Max | 63 031.4% |
Other Profitability Ratios
PHC Holdings Corp
Glance View
PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 9,374 full-time employees. The company went IPO on 2021-10-14. The firm operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for PHC Holdings Corp is 1.6%, which is above its 3-year median of -0.7%.
Over the last 3 years, PHC Holdings Corp’s Net Margin has increased from -6.5% to 1.6%. During this period, it reached a low of -6.7% on Dec 31, 2022 and a high of 3.1% on Jun 30, 2025.
